Accurate Point of Care Liver Disease Diagnostics (Phase 2) (NCT07518784)
Accurate Point of Care Liver Disease Diagnostics
🩺 Plain-English Summary (8th-Grade Level)
This research study is being conducted to find out more about techniques to non-invasively evaluate liver disease. This is the second phase of a project in which we are testing a new technology to evaluate the liver (LiverScope®). We will compare LiverScope® to other methods to evaluate the liver, including advanced conventional liver MR exams. MR exams are common exams used to monitor MASLD (also known as NAFLD). Conventional MR scanners use magnetic fields and radio waves to make pictures of the liver. LiverScope® is a small, portable MR-based device that uses similar, but simplified technology, and can be used on top of an exam table in an outpatient setting. LiverScope® currently is not approved for clinical use. In this second phase of the study, we took what we learned in the first phase to optimize the LiverScope® device and are now testing to see how LiverScope® measurements compare to MR after these optimizations. Study participants will be asked to complete a one-time visit which includes: * LiverScope exam * MR exam * FibroScan exam (optional) * Blood draw * Completion of study questionnaires
Who can join: Review the eligibility criteria below.
Location: University of California San Diego — La Jolla, California
Age range: 18 Years
🧪 Interventions in This Study
- LiverScope® exam (DIAGNOSTIC_TEST)
- MR exam (DIAGNOSTIC_TEST)
- Blood draw (DIAGNOSTIC_TEST)
- Body measurements (OTHER)
- Questionnaire (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of California San Diego — La Jolla, California
📞 Contact the Study Coordinator
Phone: (858) 246-2198
Email: ycovarrubias@health.ucsd.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in MASLD
- Influence of Metabolic Syndrome on Endogenous Oxalate Synthesis — Birmingham, Alabama
- Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease — Detroit, Michigan
- Quantitative Ultrasound to Assess Steatotic Liver Disease in Children — La Jolla, California
- A Study of Electronic Clinical Decision Support Tools for Steatotic Liver Disease — Nashville, Tennessee
- Endoscopic Ultrasound Shear Wave Elastography Study — Boston, Massachusetts
Explore by condition: All MASLD clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.